Detalles de la búsqueda
1.
Third-line treatment patterns in HER2-positive metastatic breast cancer: a retrospective analysis of real-world data in Canada.
J Pharm Pharm Sci
; 26: 12078, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38152647
2.
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.
Oncologist
; 27(10): 822-831, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830543
3.
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
Breast Cancer Res Treat
; 192(1): 153-161, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35112166
4.
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 555-564, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35230585
5.
Do Preoperative Prophylactic Antibiotics Reduce Surgical Site Infection Following Wire-Localized Lumpectomy? A Single-Blind Randomized Clinical Trial.
Ann Surg Oncol
; 29(4): 2202-2208, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34825283
6.
Women with breast cancer's perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: a qualitative study.
Support Care Cancer
; 30(6): 4759-4768, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35133477
7.
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.
Breast Cancer Res Treat
; 187(1): 155-165, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33591468
8.
Wage losses among spouses of women with nonmetastatic breast cancer.
Cancer
; 126(5): 1124-1134, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31821547
9.
Is contralateral breast ultrasound worthwhile in preoperative staging of breast cancer?
J Clin Ultrasound
; 47(4): 195-200, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30729540
10.
Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast.
J Surg Oncol
; 117(6): 1137-1143, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29205352
11.
Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.
Oncologist
; 22(1): 12-24, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864574
12.
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 565, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35507135
13.
How Wide Should Margins Be for Phyllodes Tumors of the Breast?
Breast J
; 23(3): 315-322, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27901301
14.
Is there an Upgrading to Malignancy at Surgery of Mucocele-Like Lesions Diagnosed on Percutaneous Breast Biopsy?
Breast J
; 22(2): 173-9, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26662058
15.
Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients.
Ann Pharmacother
; 48(4): 447-55, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24321851
16.
Survey about the use of scalp cooling to prevent alopecia during breast cancer chemotherapy treatment in Canada.
Can Oncol Nurs J
; 24(2): 102-8, 2014.
Artículo
en Inglés, Francés
| MEDLINE | ID: mdl-24902427
17.
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
Lancet Oncol
; 14(1): 72-80, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23246022
18.
Pilot randomized controlled trial of a program to enhance experience and adherence with adjuvant endocrine therapy among women with non-metastatic breast cancer: 12-month quantitative results.
J Cancer Surviv
; 2024 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38702555
19.
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.
Clin Cancer Res
; 30(2): 334-343, 2024 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37992310
20.
In response to: Long-term overall survival of patients diagnosed with pure tubular carcinoma of the breast might be affected by increased co-morbidities.
J Surg Oncol
; 117(7): 1615, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29601648